Ain Shams Maternity Hospital
Cairo, Egypt
NCT Number: NCT05688007
This observational study aims to test the level of parathyroid hormone in pregnant women. The main question it aims to answer is:
n Pregnant women, are the levels of serum PTH, calcium, magnesium, phosphorus & albumin similar in both preterm and term births?
Looking for future studies?
Notify Me18 year–40 year
Female
Observational
Cairo, Egypt
History: a full detailed history including personal, menstrual, obstetric, present, past history and family history will be obtained.
Accurate last menstrual period date will be obtained, and gestational age will be calculated using Naegele's rule or first trimester ultrasound to identify preterm patients with gestational age (28-36 weeks).
Examination: general, abdominal and vaginal examination to identify patients in established labor with Regular uterine contractions are at least 3 in 10 min each lasting 40 seconds. Progressive cervical dilatation (at least 4 cm). Ultrasound: for (viability of fetus, fetal biometry and estimated fetal weight, amniotic fluid, placental localization).
Thus, two groups of patients will be identified:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Serum level of parathyroid hormone
Serum levels of: magnesium, phosphorus, calcium, and albumin
Time frame: 1 day
serum level of parathyroid hormone (ng/L)
Time frame: 1 day
serum calcium level (mg/dl)
Time frame: 1 day
serum magnesium level (meq/L)
Time frame: 1 day
serum phosphorus level (mg/dl)
Time frame: 1 day
serum albumin level (g/dl)
Ain Shams Maternity Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07336173
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Kafr ash Shaykh, Egypt
View Trial DetailsNCT07695467
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Sivas, Kayseri Ave, Turkey (Türkiye)
View Trial DetailsNCT07649668
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Faisalabad, Punjab Province, Pakistan
View Trial DetailsNCT04417595
Chemically-Induced Disorders, Female Urogenital Diseases and Pregnancy Complications
Nashville, Tennessee, United States
View Trial Details